NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis $8.14 +0.30 (+3.76%) As of 10:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Nutriband Stock (NASDAQ:NTRB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nutriband alerts:Sign Up Key Stats Today's Range$8.00▼$8.2950-Day Range$6.00▼$7.8452-Week Range$3.72▼$11.78Volume26,074 shsAverage Volume123,019 shsMarket Capitalization$97.86 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingReduce Company Overview Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Read More Nutriband Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreNTRB MarketRank™: Nutriband scored higher than 37% of companies evaluated by MarketBeat, and ranked 724th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingReduce Consensus RatingNutriband has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on 1 buy rating, no hold ratings, and 2 sell ratings.Upside PotentialNutriband has a consensus price target of $13.00, representing about 65.8% upside from its current price of $7.84.Amount of Analyst CoverageNutriband has only been the subject of 2 research reports in the past 90 days.Read more about Nutriband's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nutriband are expected to grow in the coming year, from ($0.60) to ($0.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutriband is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutriband is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutriband has a P/B Ratio of 13.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Nutriband's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.60% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently increased by 14.91%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNutriband does not currently pay a dividend.Dividend GrowthNutriband does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.60% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently increased by 14.91%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Nutriband this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for NTRB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows7 people have added Nutriband to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nutriband insiders have not sold or bought any company stock.Percentage Held by Insiders54.09% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.70% of the stock of Nutriband is held by institutions.Read more about Nutriband's insider trading history. Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NTRB Stock News HeadlinesNutriband Inc. Files Provisional Patent Application to Enhance AVERSA™ Abuse Deterrent Technology for Opioid and Stimulant Patches2 hours ago | quiverquant.comQNutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology3 hours ago | globenewswire.comForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be the biggest paradigm shift ever. Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution. Click here to get the name of this company, completely free of charge...October 8 at 2:00 AM | Brownstone Research (Ad)Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference5 hours ago | globenewswire.comWall Street Zen Downgrades Nutriband (NASDAQ:NTRB) to SellSeptember 29, 2025 | americanbankingnews.comCentury Therapeutics (NASDAQ:IPSC) and Nutriband (NASDAQ:NTRB) Financial SurveySeptember 27, 2025 | americanbankingnews.comNutriband Inc. to Present at the MicroCap Rodeo ConferenceSeptember 24, 2025 | globenewswire.comNutriband reports Q2 EPS ($2.12) vs. (15c) last yearSeptember 10, 2025 | msn.comSee More Headlines NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed this year? Nutriband's stock was trading at $4.71 at the beginning of 2025. Since then, NTRB stock has increased by 66.5% and is now trading at $7.84. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) released its earnings results on Tuesday, September, 9th. The company reported ($2.12) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $1.95. The firm had revenue of $0.62 million for the quarter, compared to the consensus estimate of $0.71 million. Nutriband had a negative trailing twelve-month return on equity of 85.40% and a negative net margin of 398.29%. When did Nutriband's stock split? Nutriband's stock split on Monday, August 15th 2022.The 13-6 split was announced on Monday, August 15th 2022. The newly minted shares were issued to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nutriband own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR). Company Calendar Last Earnings9/09/2025Today10/07/2025Next Earnings (Estimated)12/02/2025Fiscal Year End1/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:NTRB CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees10Year Founded2016Price Target and Rating Average Price Target for Nutriband$13.00 High Price Target$13.00 Low Price Target$13.00 Potential Upside/Downside+65.8%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($2.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.48 million Net Margins-398.29% Pretax Margin-398.33% Return on Equity-85.40% Return on Assets-73.45% Debt Debt-to-Equity Ratio0.01 Current Ratio4.78 Quick Ratio4.70 Sales & Book Value Annual Sales$2.14 million Price / Sales44.07 Cash FlowN/A Price / Cash FlowN/A Book Value$0.58 per share Price / Book13.52Miscellaneous Outstanding Shares12,030,000Free Float5,525,000Market Cap$94.32 million OptionableNot Optionable Beta1.13 Social Links These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:NTRB) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHow to profit from the AI maniaPorter Stansberry says the AI boom’s next trillion-dollar winners won’t be chatbots or Big Tech — but the over...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.